Capricor Therapeutics (NASDAQ:CAPR) saw its stock plummet by 53% on Friday after the U.S. Food and Drug Administration issued a Complete Response Letter (CRL), rejecting the company’s bid for approval ...

Especially the small items that make cleaning and organizing faster and less demanding. With unbeatable sales on everyday ...